191 related articles for article (PubMed ID: 12053177)
1. Protein elongation factor EEF1A2 is a putative oncogene in ovarian cancer.
Anand N; Murthy S; Amann G; Wernick M; Porter LA; Cukier IH; Collins C; Gray JW; Diebold J; Demetrick DJ; Lee JM
Nat Genet; 2002 Jul; 31(3):301-5. PubMed ID: 12053177
[TBL] [Abstract][Full Text] [Related]
2. The role of protein elongation factor eEF1A2 in ovarian cancer.
Lee JM
Reprod Biol Endocrinol; 2003 Oct; 1():69. PubMed ID: 14588074
[TBL] [Abstract][Full Text] [Related]
3. The prognostic significance of elongation factor eEF1A2 in ovarian cancer.
Pinke DE; Kalloger SE; Francetic T; Huntsman DG; Lee JM
Gynecol Oncol; 2008 Mar; 108(3):561-8. PubMed ID: 18164751
[TBL] [Abstract][Full Text] [Related]
4. eEF1A2 as a putative oncogene.
Lee MH; Surh YJ
Ann N Y Acad Sci; 2009 Aug; 1171():87-93. PubMed ID: 19723040
[TBL] [Abstract][Full Text] [Related]
5. Characterization of a putative ovarian oncogene, elongation factor 1alpha, isolated by panning a synthetic phage display single-chain variable fragment library with cultured human ovarian cancer cells.
Sharma S; Tammela J; Wang X; Arnouk H; Driscoll D; Mhawech-Fauceglia P; Lele S; Kazim AL; Odunsi K
Clin Cancer Res; 2007 Oct; 13(19):5889-96. PubMed ID: 17908984
[TBL] [Abstract][Full Text] [Related]
6. Expression of protein elongation factor eEF1A2 predicts favorable outcome in breast cancer.
Kulkarni G; Turbin DA; Amiri A; Jeganathan S; Andrade-Navarro MA; Wu TD; Huntsman DG; Lee JM
Breast Cancer Res Treat; 2007 Mar; 102(1):31-41. PubMed ID: 16897428
[TBL] [Abstract][Full Text] [Related]
7. Tumor promoting properties of the ETS protein MEF in ovarian cancer.
Yao JJ; Liu Y; Lacorazza HD; Soslow RA; Scandura JM; Nimer SD; Hedvat CV
Oncogene; 2007 Jun; 26(27):4032-7. PubMed ID: 17213815
[TBL] [Abstract][Full Text] [Related]
8. Resveratrol suppresses growth of human ovarian cancer cells in culture and in a murine xenograft model: eukaryotic elongation factor 1A2 as a potential target.
Lee MH; Choi BY; Kundu JK; Shin YK; Na HK; Surh YJ
Cancer Res; 2009 Sep; 69(18):7449-58. PubMed ID: 19738051
[TBL] [Abstract][Full Text] [Related]
9. Regulation and functional role of eEF1A2 in pancreatic carcinoma.
Cao H; Zhu Q; Huang J; Li B; Zhang S; Yao W; Zhang Y
Biochem Biophys Res Commun; 2009 Feb; 380(1):11-6. PubMed ID: 19138673
[TBL] [Abstract][Full Text] [Related]
10. eEF1A2 activates Akt and stimulates Akt-dependent actin remodeling, invasion and migration.
Amiri A; Noei F; Jeganathan S; Kulkarni G; Pinke DE; Lee JM
Oncogene; 2007 May; 26(21):3027-40. PubMed ID: 17130842
[TBL] [Abstract][Full Text] [Related]
11. Functional evidence for an ovarian cancer tumor suppressor gene on chromosome 22 by microcell-mediated chromosome transfer.
Kruzelock RP; Cuevas BD; Wiener JR; Xu FJ; Yu Y; Cabeza-Arvelaiz Y; Pershouse M; Lovell MM; Killary AM; Mills GB; Bast RC
Oncogene; 2000 Dec; 19(54):6277-85. PubMed ID: 11175342
[TBL] [Abstract][Full Text] [Related]
12. [Construction of autocatalytic caspase-3 driven by amplified human telomerase reverse transcriptase promoter and its enhanced efficacy of inducing apoptosis in human ovarian carcinoma].
Song Y; Shen K; He CX
Zhonghua Fu Chan Ke Za Zhi; 2007 Sep; 42(9):617-22. PubMed ID: 17983518
[TBL] [Abstract][Full Text] [Related]
13. Female mice chimeric for expression of the simian virus 40 TAg under control of the MISIIR promoter develop epithelial ovarian cancer.
Connolly DC; Bao R; Nikitin AY; Stephens KC; Poole TW; Hua X; Harris SS; Vanderhyden BC; Hamilton TC
Cancer Res; 2003 Mar; 63(6):1389-97. PubMed ID: 12649204
[TBL] [Abstract][Full Text] [Related]
14. Oncogenic role of eIF-5A2 in the development of ovarian cancer.
Guan XY; Fung JM; Ma NF; Lau SH; Tai LS; Xie D; Zhang Y; Hu L; Wu QL; Fang Y; Sham JS
Cancer Res; 2004 Jun; 64(12):4197-200. PubMed ID: 15205331
[TBL] [Abstract][Full Text] [Related]
15. [The efficacy of autocatalytic casapse-3 driven by human telomerase reverse transcriptase promoter on human ovarian carcinoma].
Song Y; Shen K; Yu JR
Zhonghua Yi Xue Za Zhi; 2007 Nov; 87(41):2919-24. PubMed ID: 18261307
[TBL] [Abstract][Full Text] [Related]
16. [Establishment of human ovarian carcinoma cell lines with directional highly lymphatic metastasis and study of their biological characteristics].
Ruan HY; Li DR; Li L; Guan X; Zhang W
Zhonghua Fu Chan Ke Za Zhi; 2007 Jul; 42(7):482-6. PubMed ID: 17961340
[TBL] [Abstract][Full Text] [Related]
17. Loss of MKP3 mediated by oxidative stress enhances tumorigenicity and chemoresistance of ovarian cancer cells.
Chan DW; Liu VW; Tsao GS; Yao KM; Furukawa T; Chan KK; Ngan HY
Carcinogenesis; 2008 Sep; 29(9):1742-50. PubMed ID: 18632752
[TBL] [Abstract][Full Text] [Related]
18. Characterization of CSOC 882, a novel immortalized ovarian cancer cell line expressing EGFR, HER2, and activated AKT.
Scoles DR; Pavelka J; Cass I; Tran H; Baldwin RL; Armstrong K; Karlan BY
Gynecol Oncol; 2007 Jan; 104(1):120-8. PubMed ID: 16956650
[TBL] [Abstract][Full Text] [Related]
19. Comparison of the EF-1 alpha and the CMV promoter for engineering stable tumor cell lines using recombinant adeno-associated virus.
Teschendorf C; Warrington KH; Siemann DW; Muzyczka N
Anticancer Res; 2002; 22(6A):3325-30. PubMed ID: 12530082
[TBL] [Abstract][Full Text] [Related]
20. The eukaryotic translation elongation factor eEF1A2 induces neoplastic properties and mediates tumorigenic effects of ZNF217 in precursor cells of human ovarian carcinomas.
Sun Y; Wong N; Guan Y; Salamanca CM; Cheng JC; Lee JM; Gray JW; Auersperg N
Int J Cancer; 2008 Oct; 123(8):1761-9. PubMed ID: 18661515
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
